Submit Deal

Announced

1 Mar 2019

Completed

18 Mar 2019

Clean Cells completed the acquisition of BE Vaccines from Biological E.

Synopsis

Clean Cells, a CRO specialized in biosafety testing completed the acquisition of BE Vaccines, a French subsidiary of the Indian Pharmaceutical Company Biological E. Financial terms were not disclosed.

Principals

target

Be Vaccines

bidder

Clean Cells

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Bidder Team (8)

ugo audouard

Counsel at Lamartine Conseil

Lawyer

bidder

Deals

£ 510 M

Total Value

frederic maurel

Associate at Mazars Corporate Finance

Lawyer

bidder

Deal

n/a

Total Value

marine cambolin

Associate at Mazars Corporate Finance

Lawyer

bidder

Deals

n/a

Total Value

sandrine vouillon

Mazars Corporate Finance

Lawyer

bidder

Deals

n/a

Total Value

mathilde toussaint

Director at Mazars Corporate Finance

Lawyer

bidder

Deal

n/a

Total Value

sarah latour

ECR Environnement

Commercial Consultant

bidder

Deal

n/a

Total Value

benoit brossard

Associate at Oratio Avocats

Lawyer

bidder

Deal

n/a

Total Value

olivier boisteau

CEO at CLEAN CELLS

Manager

bidder

Deal

n/a

Total Value

Vendor Team (3)

thomas gross

Associate Director at Sogedev

Commercial Consultant

vendor

Deal

n/a

Total Value

benoit marpeau

Partner at Dethomas-Peltier-Juvigny

Lawyer

vendor

Deals

n/a

Total Value

guillaume fornier

Counsel at Dethomas-Peltier-Juvigny

Lawyer

vendor

Deal

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy